sanguisorbae radix
Recently Published Documents


TOTAL DOCUMENTS

26
(FIVE YEARS 4)

H-INDEX

9
(FIVE YEARS 1)

2021 ◽  
Vol 12 ◽  
Author(s):  
Eun-Ji Lee ◽  
Ji Hye Kim ◽  
Tae In Kim ◽  
Yeon-Ji Kim ◽  
Malk Eun Pak ◽  
...  

Immune checkpoints such as programmed death-1 (PD-1) have been proven as antitumor targets by enhancing cytotoxic T cell activity. All immune checkpoint blockades are antibody therapeutics that have large size and high affinity, as well as known immune-related side effects and low responses. To overcome the limitation of antibody therapeutics, we have explored PD-1/PD-L1 (programmed death-ligand 1) blockades in traditional oriental medicine, which has a long history but has not yet studied PD-1/PD-L1 blockades. Sanguisorbae Radix extract (SRE) blocked PD-1 and PD-L1 binding in competitive ELISA. SRE effectively inhibited the PD-1/PD-L1 interaction, thereby improving T cell receptor (TCR) signaling and the NFAT-mediated luciferase activity of T cells. SRE treatment reduced tumor growth in the humanized PD-L1 MC38 cell allograft humanized PD-1 mouse model. Additionally, the combination of SRE and pembrolizumab (anti-PD-1 antibody) suppressed tumor growth and increased infiltrated cytotoxic T cells to a greater extent did either agent alone. This study showed that SRE alone has anticancer effects via PD-1/PD-L1 blockade and that the combination therapy of SRE and pembrolizumab has enhanced immuno-oncologic effects.


2020 ◽  
Vol 18 ◽  
Author(s):  
Rishabh Verma ◽  
Kanchan Devi ◽  
Farheen Fatima Qizibash ◽  
Surajpal Verma ◽  
Manish Vyas ◽  
...  

Abstract:: Coronavirus disease-2019(COVID-19) is gaining much popularity not only in the Wuhan city of China but internationally also, in January 2020, the corona is speeded to many countries like the USA, Italy, Russia, India, Singapore, Pakistan, Thailand, Canada, Australia, England, and so on through passengers having a travel history of other countries. Corona patients can be cure with synthetic, some traditional herbal medicines (THM), Vitamin D and quarantine approach. Different allopathic medicine, herbal extracts, and vitamin D can be used to treat novel corona virus-like Remdesivir, hydroxychloroquine, Teicoplanin, Lopinavir+ Ritonavir, Ribavirin +corticosteroids, etc. Glycyrrhizin, Sanguisorbae radix, Acanthopanacis cortex, Sophorae radix, etc. and vitamin D. Coronavirus can be treated with these strategies. Various antiviral drugs are used to treat COVID-19, alone or in combination with other drugs like Interferon-α, Lopinavir + Ritonavir, Arbidol, corticosteroids, etc. and some herbal extracts, Quarantine and Vitamin D that not only cure the infection, also boosts up our immunity. To prepare this review article, different papers were searched by google scholar, scopus, WHO’s website, PubMed, clinicaltrials.gov and other relevant scientific archiving services. In this review article, we are going to discuss the current strategies that are using to treat COVID-19. With allopathic drugs some herbal extracts are also there that can be used to treat this novel corona virus-like Glycyrrhizin, Sanguisorbae radix, Acanthopanacis cortex, Sophorae radix, etc and vitamin D.


Cosmetics ◽  
2019 ◽  
Vol 6 (4) ◽  
pp. 68
Author(s):  
Young-Ah Jang ◽  
Yong Hur ◽  
Jin-Tae Lee

Sanguisorbae Radix (SR) is the root of the Sanguisorba officinalis L., a plant native to Asian countries and used in traditional medicine. We isolated the active components of SR and investigated their anti-inflammatory potential. Quercetin (QC), (+)-catechin (CC), and gallic acid (GA) were isolated from acetone extracts of SR. To elucidate the molecular mechanism by which these compounds suppress inflammation, we analyzed the transcriptional up-regulation of inflammatory mediators, such as nuclear factor-kappa B (NF-κB) and its target genes, inducible NOS (iNOS), and cyclooxygenase (COX)-2, in lipopolysaccharide (LPS)-stimulated macrophage RAW264.7 cells. Notably, QC, CC, and GA were found to inhibit the production of nitric oxide, tumor necrosis factor-alpha, and prostaglandin in a dose-dependent manner. Western blot results indicate that the compounds decreased the expression of iNOS and COX-2 proteins. Furthermore, the compounds decreased phosphorylation of IKK, IκB, ERK, p-38, and JNK proteins in LPS-induced cells. The results support the notion that QC, CC, and GA can potently inhibit the inflammatory response, with QC showing the highest anti-inflammatory activity. In in vivo toxicity studies in zebrafish (Danio rerio), QC showed no toxicity up to 25 μg/mL. Therefore, QC has non-toxic potential as a skin anti-inflammatory biomaterial.


2019 ◽  
Vol 29 (2) ◽  
pp. 252-256 ◽  
Author(s):  
Ji Hoon Song ◽  
Song-Yi Kim ◽  
Gwi Seo Hwang ◽  
Youn-Sub Kim ◽  
Hyun Young Kim ◽  
...  
Keyword(s):  

2016 ◽  
Vol 2016 ◽  
pp. 1-8 ◽  
Author(s):  
Ju-Hye Yang ◽  
Jae-Myung Yoo ◽  
Won-Kyung Cho ◽  
Jin Yeul Ma

Sanguisorbae Radix (SR) is well known as herbal medicine named “Zi-Yu” in Korea, which is the dried roots ofSanguisorba officinalisL. (Rosacease). We investigated the underlying mechanism on the inhibition of atopic dermatitis (AD) of an ethanol extract of SR (ESR) using 2,4-dinitrochlorobenzene- (DNCB-) induced AD mice model. Oral administration of ESR significantly suppressed DNCB-induced AD-like symptoms such as scratching behavior, ear thickness, epidermal thickness, and IgE levels. To investigate the effects of ESR treatment on degranulation of IgE/Ag-activated mouse bone marrow-derived mast cells (BMMCs), we measured the release ofβ-hexosaminidase (β-HEX, degranulation marker). ESR decreased the infiltration of eosinophils and mast cells into the AD skin lesions. Furthermore, ESR significantly inhibited degranulation of IgE/Ag-activated BMMCs. We have demonstrated that ESR decreased AD symptoms in mice and inhibits degranulation of IgE/Ag-activated mast cells. Our study suggests that ESR may serve as a potential therapeutic candidate for the treatment of AD symptoms.


2015 ◽  
Vol 26 (9) ◽  
pp. 688-693 ◽  
Author(s):  
Suzy Jo ◽  
Junghyun Ryu ◽  
Hanna Kim ◽  
Miyoung Kim ◽  
Mi Heon Ryu ◽  
...  

2015 ◽  
Vol 30 (4) ◽  
pp. 29-35 ◽  
Author(s):  
Ki-Jung Kil ◽  
Eun-Soo Doh ◽  
Jun-Pok Chang ◽  
Seung-Hyun Lee ◽  
Ji-Hyun Yoo

2014 ◽  
Vol 70 ◽  
pp. 615-620 ◽  
Author(s):  
Zhigang Wu ◽  
Honghui Sun ◽  
Jingzhong Li ◽  
Chijiao Ma ◽  
Siqiao Zhao ◽  
...  

2014 ◽  
Vol 6 (3) ◽  
pp. 222-227 ◽  
Author(s):  
Yong-ai Xiong ◽  
Qi-nan Yu ◽  
Jun-bo Zou ◽  
Yi-hang He ◽  
Shuai-jie Zhang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document